This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Inside Edition: TMS Helmet Was the Missing Puzzle Piece for One Young Patient
From teenager to young adult studying at NorthEastern University, countless courses of medication were never able to solve one young woman’s struggle with depression. Once her psychiatrist recommended Deep TMS, “it was like a weight was lifted off [her].” Inside Edition profiles her inspirational story.